Venmax Drugs & Pharmaceuticals Ltd

NSE: VENMAX · BSE: 531015 · Pharmaceuticals & Biotechnology · 17 announcements

Share price: ₹14.89
Market cap: ₹13.08 Cr
Revenue (annual): ₹8.02 Cr
Net profit (annual): ₹0.25 Cr
P/E (TTM): 46.7×Sector 47.3×
Promoter holding: 10.46%-3.34% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Other Announcement 3 Financial Results 3 Board Meeting Date 3 Capital Structure Change 2 Acquisition 2 Debt & Borrowing 1 Board Meeting Outcome 1 Annual Report 1 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

3 announcements with these filters

24 Aug 2026 12:51 IST BSE

Board Meeting Date

Venmax Drugs & Pharmaceuticals Board Meeting Date

Venmax Drugs & Pharmaceuticals scheduled a board meeting for August 31, 2026. The board will approve the 37th Annual Report and fix details for the Annual General Meeting.

Read the filing ↗

1 Aug 2026 15:41 IST BSE

Board Meeting Date

Venmax Drugs & Pharmaceuticals Board Meeting Date

Venmax Drugs and Pharmaceuticals has scheduled a board meeting for August 7, 2026, to consider quarterly financial results and forfeiture of partly paid-up share warrants.

Read the filing ↗

6 May 2026 16:57 IST BSE

Board Meeting Date

Venmax Drugs & Pharmaceuticals Board Meeting Date

Venmax Drugs and Pharmaceuticals Ltd has scheduled a Board Meeting on May 14, 2026. The board will consider and approve the audited financial results for the quarter and year ended March 31, 2026. The company's trading window remains closed until May 16, 2026.

Read the filing ↗